Business context and reporting period
This is KWESST Micro Systems Inc.’s audited annual report on Form 20-F for the fiscal year ended September 30, 2022; it includes results for fiscal Q4. The filing is for KWESST, not DEFSEC Technologies Inc. Unless noted otherwise, amounts below are Canadian dollars (CAD). The statements use IFRS.
KWESST develops tactical technology for military, public-safety and personal-defense markets. Its lines include non-lethal ARWEN and PARA OPS products, digitization systems and counter-threat products such as Phantom and the Battlefield Laser Defense System (BLDS). Most products were still pre-commercial or at low-rate production; ARWEN was the principal product line in full production.
Financial performance and position
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $721,519 | $1,275,804 |
| Gross profit / margin | $184,784 / 25.6% | $476,916 / 37.4% |
| Operating expenses | $10,276,129 | $9,679,464 |
| Operating loss | $(10,091,345) | $(9,202,548) |
| Net loss | $(10,520,290) | $(9,315,372) |
| Adjusted EBITDA loss (non-IFRS) | $(7,297,670) | $(6,599,351) |
| Operating cash flow | $(4,256,596) | $(6,255,213) |
| Cash at year-end | $170,545 | $2,688,105 |
Fiscal Q4 revenue was $255,371, up 60% from $160,047 in the prior-year quarter, principally reflecting the Police Ordnance acquisition. Q4 net loss improved to $2,344,944 from $2,884,067, with operating expenses down 21% to $2.3 million.
FY 2022 revenue fell 43%, mainly because the prior year included a larger U.S. military contract; ARWEN sales partly offset the decline. Lower revenue and higher operating costs contributed to the wider annual loss. Net finance costs increased to $506,002, chiefly due to borrowings and accretion on the PARA OPS royalty liability. Revenue by product category was $354,620 digitization, $330,658 non-lethal, $34,590 training and services, and $1,651 other. One customer accounted for 41% of annual revenue.
At September 30, 2022, total assets were $7.32 million and liabilities were $8.33 million, leaving a shareholders’ deficit of $1.00 million. Current assets of $1.52 million compared with current liabilities of $6.93 million, resulting in negative working capital of $5.41 million. Borrowings were $2.28 million, in addition to $275,621 in lease obligations and $1.27 million in accrued royalties. Accounts payable and accrued liabilities totaled $4.46 million.
Cash used in investing activities was $1.11 million; financing activities provided $2.85 million. The auditor issued an unmodified opinion but highlighted substantial doubt about the company’s ability to continue as a going concern, citing recurring losses, negative operating cash flow and negative working capital.
Material changes and subsequent financing
- Revenue declined and gross margin contracted year over year, while net loss and adjusted EBITDA loss increased.
- The December 2021 Police Ordnance acquisition added the ARWEN product line and law-enforcement customer base. Management reported $355,296 of acquired-company revenue and a $198,353 net loss contribution from acquisition through year-end.
- KWESST raised gross proceeds of approximately US$14.1 million through its U.S. IPO and Canadian offering, which closed December 9, 2022, after year-end. Estimated net proceeds were approximately US$11 million after offering costs. The company reported that it repaid its outstanding loans in December 2022, including CEBA loans.
- A 1-for-70 reverse stock split took effect October 28, 2022, and shares began trading on Nasdaq in December 2022. The filing states that reported share and per-share data reflect the reverse split.
Outlook, risks and unusual items
Management anticipated FY 2023 revenue growth from PARA OPS commercialization, full-year ARWEN sales and prospective military contracts. The company reported a first BLDS order in November 2022 for US$330,000, expected for delivery by June 2023; follow-on orders were uncertain. Potential awards and contract values described in the filing are contingent, not assured guidance. Management expected personnel costs to rise approximately 10%–15% in FY 2023 and intended to seek to pass those increases to customers.
Key risks include continued cash burn and reliance on financing; uncertainty over product readiness, market acceptance and customer-contract timing; dependence on suppliers and outsourced manufacturing; government procurement, export and product-classification rules; and competition, inflation, supply-chain disruption, currency exposure and product liability. In the United States, PARA OPS devices were self-classified as firearms and the .67-caliber version as a “destructive device,” subject to ATF rules; management was developing a version intended to qualify as an “any other weapon.” The PARA OPS acquisition from Executive Chairman David Luxton’s company DEFSEC carries a 7% royalty and minimum royalty commitments totaling $2.5 million, subject to agreement terms. The filing also notes that AerialX had not delivered a functional prototype and that the related drone project was not a near-term revenue driver.
The financing raised after year-end improved the stated liquidity position, but the going-concern warning applies to the September 30, 2022 financial statements. Commercial execution, future cash needs and the use of IPO proceeds remain important uncertainties. The company reported effective disclosure controls; it did not include management’s internal-control effectiveness assessment or an auditor attestation, citing its transition-period exemption.
Investor verification priorities
- Confirm current cash, cash runway, and actual net proceeds and deployment from the December 2022 offerings; reconcile the reported loan repayments and any remaining obligations.
- Track quarterly sales, gross margins, operating cash burn and working capital against the FY 2023 commercialization plans.
- Verify PARA OPS regulatory status, launch progress, sales traction and the cash impact of royalty minimums and the related-party agreement.
- Assess customer concentration and whether announced or prospective military, BLDS and digitization opportunities convert into funded orders and collected cash.
- Review dilution from IPO units, warrants, options and other securities, as well as compliance with Nasdaq listing requirements.